95 related articles for article (PubMed ID: 15179015)
1. Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia.
Scassellati C; Bonvicini C; Perez J; Bocchio-Chiavetto L; Tura GB; Rossi G; Racagni G; Gennarelli M
Neuropsychobiology; 2004; 50(1):16-20. PubMed ID: 15179015
[TBL] [Abstract][Full Text] [Related]
2. Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.
Park SW; Lee JG; Kong BG; Lee SJ; Lee CH; Kim JI; Kim YH
Psychiatry Clin Neurosci; 2009 Aug; 63(4):433-9. PubMed ID: 19457211
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.
Szczepankiewicz A; Skibinska M; Hauser J; Slopien A; Leszczynska-Rodziewicz A; Kapelski P; Dmitrzak-Weglarz M; Czerski PM; Rybakowski JK
Neuropsychobiology; 2006; 53(1):51-6. PubMed ID: 16397405
[TBL] [Abstract][Full Text] [Related]
4. Association between glycogen synthase kinase-3beta gene polymorphisms and major depression and suicidal behavior in a Korean population.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):331-4. PubMed ID: 20015462
[TBL] [Abstract][Full Text] [Related]
5. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.
Lee KY; Ahn YM; Joo EJ; Jeong SH; Chang JS; Kim SC; Kim YS
Neurosci Lett; 2006 Mar; 395(2):175-8. PubMed ID: 16289845
[TBL] [Abstract][Full Text] [Related]
6. Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.
Blasi G; Napolitano F; Ursini G; Di Giorgio A; Caforio G; Taurisano P; Fazio L; Gelao B; Attrotto MT; Colagiorgio L; Todarello G; Piva F; Papazacharias A; Masellis R; Mancini M; Porcelli A; Romano R; Rampino A; Quarto T; Giulietti M; Lipska BK; Kleinman JE; Popolizio T; Weinberger DR; Usiello A; Bertolino A
Am J Psychiatry; 2013 Aug; 170(8):868-76. PubMed ID: 23598903
[TBL] [Abstract][Full Text] [Related]
7. No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population.
Meng J; Shi Y; Zhao X; Zhou J; Zheng Y; Tang R; Ma G; Zhu X; He Z; Wang Z; Xu Y; Feng G; He L
J Psychiatr Res; 2008 Apr; 42(5):365-70. PubMed ID: 17368486
[TBL] [Abstract][Full Text] [Related]
8. Association between glycogen synthase kinase-3β gene polymorphisms and attention deficit hyperactivity disorder in Korean children: a preliminary study.
Shim SH; Hwangbo Y; Kwon YJ; Lee HY; Kim JH; Yoon HK; Hwang JA; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):57-61. PubMed ID: 22658982
[TBL] [Abstract][Full Text] [Related]
9. Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders.
Serretti A; Benedetti F; Mandelli L; Calati R; Caneva B; Lorenzi C; Fontana V; Colombo C; Smeraldi E
Psychiatry Res; 2008 Mar; 158(2):132-40. PubMed ID: 17976739
[TBL] [Abstract][Full Text] [Related]
10. Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult.
Kozlovsky N; Nadri C; Agam G
Eur Neuropsychopharmacol; 2005 Jan; 15(1):1-11. PubMed ID: 15572268
[TBL] [Abstract][Full Text] [Related]
11. [Haplotype analysis of GSK-3beta gene polymorphisms and smoking behavior].
Numajiri M; Iwahashi K; Nishizawa D; Ikeda K; Yoshihara E; Ishigooka J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):175-8. PubMed ID: 25069254
[TBL] [Abstract][Full Text] [Related]
12. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
Nadri C; Dean B; Scarr E; Agam G
Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
[TBL] [Abstract][Full Text] [Related]
13. GSK-3 parameters in lymphocytes of schizophrenic patients.
Nadri C; Kozlovsky N; Agam G; Bersudsky Y
Psychiatry Res; 2002 Sep; 112(1):51-7. PubMed ID: 12379450
[TBL] [Abstract][Full Text] [Related]
14. The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients.
Lee YJ; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1303-8. PubMed ID: 21549170
[TBL] [Abstract][Full Text] [Related]
15. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
[TBL] [Abstract][Full Text] [Related]
16. [The relationship between glycogen synthase kinase - 3beta -1727A/T x -50T/C genetic polymorphisms and nicotine dependence].
Numajiri M; Nishizawa D; Ikeda K; Yoshihara E; Iwahashii K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2013 Oct; 48(5):293-9. PubMed ID: 24427901
[TBL] [Abstract][Full Text] [Related]
17. Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.
Kozlovsky N; Shanon-Weickert C; Tomaskovic-Crook E; Kleinman JE; Belmaker RH; Agam G
J Neural Transm (Vienna); 2004 Dec; 111(12):1583-92. PubMed ID: 15565492
[TBL] [Abstract][Full Text] [Related]
18. No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.
Ikeda M; Iwata N; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Ozaki N
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):90-2. PubMed ID: 15719395
[TBL] [Abstract][Full Text] [Related]
19. [Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders].
Ivanova SA; Losenkov IS; Bokhan NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(6):93-100. PubMed ID: 25075421
[TBL] [Abstract][Full Text] [Related]
20. Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
Benedetti F; Poletti S; Radaelli D; Bernasconi A; Cavallaro R; Falini A; Lorenzi C; Pirovano A; Dallaspezia S; Locatelli C; Scotti G; Smeraldi E
Genes Brain Behav; 2010 Jun; 9(4):365-71. PubMed ID: 20113358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
